0001832334-20-000001.txt : 20201116
0001832334-20-000001.hdr.sgml : 20201116
20201116141033
ACCESSION NUMBER: 0001832334-20-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20201116
DATE AS OF CHANGE: 20201116
EFFECTIVENESS DATE: 20201116
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cyrano Therapeutics, Inc.
CENTRAL INDEX KEY: 0001832334
IRS NUMBER: 461891229
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-380646
FILM NUMBER: 201315517
BUSINESS ADDRESS:
STREET 1: 5125 MACARTHUR BLVD. NW, #20
CITY: WASHINGTON
STATE: DC
ZIP: 20016
BUSINESS PHONE: 1 (925) 822-6461
MAIL ADDRESS:
STREET 1: 5125 MACARTHUR BLVD. NW, #20
CITY: WASHINGTON
STATE: DC
ZIP: 20016
D
1
primary_doc.xml
X0708
D
LIVE
0001832334
Cyrano Therapeutics, Inc.
5125 MACARTHUR BLVD. NW, #20
WASHINGTON
DC
DISTRICT OF COLUMBIA
20016
1 (925) 822-6461
DELAWARE
None
None
Corporation
true
Richard
Geoffrion
5125 MacArthur Blvd. NW, #20
Washington
DC
DISTRICT OF COLUMBIA
20016
Executive Officer
Director
Robert
Henkin
5125 MacArthur Blvd. NW, #20
Washington
DC
DISTRICT OF COLUMBIA
20016
Director
Takahide
Koda
1601 Fifth Avenue, Suite 1100
Seattle
WA
WASHINGTON
98101-3603
Director
Gerry
Brunk
141 Adelaide Street West, Suite 770
Toronto
A6
ONTARIO, CANADA
M5H 3L5
Director
Other Health Care
Decline to Disclose
- 06b
false
2020-11-04
true
true
false
0
12804250
4082754
8721496
false
11
0
0
0
false
Cyrano Therapeutics, Inc.
Richard Geoffrion
Richard Geoffrion
President
2020-11-05